Lymphatic vessel activation in cancer

被引:50
作者
Das, Suvendu [1 ]
Skobe, Mihaela [1 ]
机构
[1] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA
来源
LYMPHATIC CONTINUUM REVISITED | 2008年 / 1131卷
关键词
lymphangiogenesis; lymphatic endothelium; lymphatic metastasis; sentinel lymph node biopsy; VEGF; VEGFR;
D O I
10.1196/annals.1413.021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Most cancerous lesions metastasize through the lymphatic system and the status of regional lymph nodes is the most important indicator of a patient's prognosis. The extent of lymph node involvement with cancer is also an important parameter used for determining treatment options. Although the importance of the lymphatic system for metastasis has been well recognized, traditionally, the lymphatic vessels have not been considered actively involved in the metastatic process. Recent evidence, however, indicates that the activation of the lymphatic system is an important factor in tumor progression to metastasis. Tumor lymphangiogenesis has been associated with increased propensity for metastasis, and lymphatic vessel density has emerged as another promising prognostic indicator. More recently, lymphangiogenesis in the sentinel lymph nodes has been shown to contribute to malignant progression. In addition to its role as a transport system for tumor cells, the lymphatic system may also be more actively involved in metastases by directly facilitating tumor cell recruitment into the lymphatic vessels. This review highlights recent advances in our understanding of the mechanisms by which lymphatic vessels participate in metastasis.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 84 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]   B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization [J].
Angeli, V ;
Ginhoux, F ;
Llodrá, J ;
Quemeneur, L ;
Frenette, PS ;
Skobe, M ;
Jessberger, R ;
Merad, M ;
Randolph, GJ .
IMMUNITY, 2006, 24 (02) :203-215
[4]   Sentinel lymph node biopsy in colon cancer -: A prospective multicerlter trial [J].
Bembenek, Andreas E. ;
Rosenberg, Robert ;
Wagler, Elke ;
Gretschel, Stephan ;
Sendler, Andreas ;
Siewert, Joerg-Ruediger ;
Naehrig, Joerg ;
Witzigmann, Helmut ;
Hauss, Johann ;
Knorr, Christian ;
Dimmler, Arno ;
Groene, Joern ;
Buhr, Heinz-Johannes ;
Haier, Joerg ;
Herbst, Hermann ;
Tepel, Juergen ;
Siphos, Bence ;
Kleespies, Axel ;
Koenigsrainer, Alfred ;
Stoecklein, Nikolas H. ;
Horstmann, Olaf ;
Gruetzmann, Robert ;
Imdahl, Andreas ;
Svoboda, Daniel ;
Wittekind, Christian ;
Schneider, Wolfgang ;
Wernecke, Klaus-Dieter ;
Schlag, Peter M. .
ANNALS OF SURGERY, 2007, 245 (06) :858-863
[5]   Local excision and postoperative radiotherapy for distal rectal cancer [J].
Benson, R ;
Wong, CS ;
Cummings, BJ ;
Brierley, J ;
Catton, P ;
Ringash, J ;
Abdolell, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05) :1309-1316
[6]   Opinion - Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis [J].
Cao, YH .
NATURE REVIEWS CANCER, 2005, 5 (09) :735-743
[7]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[8]   Lymphatic vessel activation in cancer [J].
Cassella, M ;
Skobe, M .
LYMPHATIC CONTINUUM: LYMPHATIC BIOLOGY AND DISEASE, 2002, 979 :120-130
[9]   Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma [J].
Cheng, L ;
Jones, TD ;
Lin, HQ ;
Eble, JN ;
Zeng, G ;
Carr, MD ;
Koch, MO .
JOURNAL OF UROLOGY, 2005, 174 (06) :2181-2185
[10]  
Cochran AJ, 2000, CANCER, V89, P236, DOI 10.1002/1097-0142(20000715)89:2<236::AID-CNCR5>3.0.CO